Smoking Cessation Pipeline Insight 2024, with Focus on Emerging Drugs Cytisinicline (Achieve Life Sciences), EMB-001(Embera Pharmaceuticals) and SBP-9330 (Camino Pharma)
November 25, 2024 07:54 ET
|
Research and Markets
Dublin, Nov. 25, 2024 (GLOBE NEWSWIRE) -- The "Smoking Cessation - Pipeline Insight, 2024" has been added to ResearchAndMarkets.com's offering.The report provides comprehensive insights about 10+...
Tobacco Alternative Gums Market Report 2024: Global Long-term Forecasts to 2028 and 2033
September 25, 2024 11:26 ET
|
Research and Markets
Dublin, Sept. 25, 2024 (GLOBE NEWSWIRE) -- The "Tobacco Alternative Gums Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The tobacco alternative gums market size has...
Smoking Cessation And Nicotine De-addiction Market Size, Share & Trends Analysis Report 2024-2030
September 20, 2024 04:45 ET
|
Research and Markets
Dublin, Sept. 20, 2024 (GLOBE NEWSWIRE) -- The "Smoking Cessation And Nicotine De-addiction Market Size, Share & Trends Analysis Report By Type (Nicotine Replacement Therapy), By Form, By...
Tobacco Alternative Gums Market Strategic Business Report 2024: Introduction of Sugar-Free and Low-Calorie Options
August 21, 2024 10:32 ET
|
Research and Markets
Dublin, Aug. 21, 2024 (GLOBE NEWSWIRE) -- The "Tobacco Alternative Gums - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Tobacco...
Achieve Life Sciences Reports Financial Results for Second Quarter 2024 and Provides Corporate Update
August 13, 2024 16:01 ET
|
Achieve Life Sciences
SEATTLE and VANCOUVER, British Columbia, Aug. 13, 2024 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a late-stage pharmaceutical company dedicated to the global development and...
Ayrton Saunders Announces Landmark UK MHRA Approval of Next Generation Nicotine Inhaler System for Rapid, Safe Relief of Nicotine Craving to Aid Smoking Cessation
June 25, 2024 03:00 ET
|
OBG Pharma
Becomes the world's first and only clinically approved nicotine inhaler enabling rapid absorption via the lungs to help smokers replace, cut down, and ultimately quit smokingAs a General Sales List...
$53.8+ Billion Smoking Cessation & Nicotine De-Addiction Product Market Report, 2024-2030: Business Opportunities for Drug Therapy, E-Cigarettes, and Nicotine Inhalers
June 21, 2024 09:18 ET
|
Research and Markets
Dublin, June 21, 2024 (GLOBE NEWSWIRE) -- The "Global Smoking Cessation & Nicotine De-Addiction Product Market 2024-2030" report has been added to ResearchAndMarkets.com's offering.The Smoking...
United States Health Coaching Market Outlook & Forecasts 2024-2029: Growing Focus on Corporate Wellness, Advancements & New Initiatives, Growing Preference for Online and Digital Platforms
June 13, 2024 11:41 ET
|
Research and Markets
Dublin, June 13, 2024 (GLOBE NEWSWIRE) -- The "U.S. Health Coaching Market - Industry Outlook & Forecast 2024-2029" report has been added to ResearchAndMarkets.com's offering.The U.S. Health...
Achieve Life Sciences Announces Initiation of ORCA-OL Clinical Trial Evaluating Long-Term Exposure of Cytisinicline in People who Smoke or Use Nicotine E-Cigarettes
May 29, 2024 08:00 ET
|
Achieve Life Sciences
SEATTLE and VANCOUVER, British Columbia, May 29, 2024 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), or Achieve, a late-stage pharmaceutical company committed to the global...
Achieve Life Sciences Reports Financial Results for First Quarter 2024 and Provides Corporate Update
May 09, 2024 16:01 ET
|
Achieve Life Sciences
SEATTLE and VANCOUVER, British Columbia, May 09, 2024 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a late-stage pharmaceutical company dedicated to the global development and...